{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:14:58Z","timestamp":1792703698472,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1836,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/s41379-018-0081-z","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T07:13:35Z","timestamp":1529997215000},"page":"1661-1674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Gregor","family":"Krings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunn-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-018-0081-z_bib1","series-title":"WHO classification of tumours of the breast","first-page":"48","article-title":"Metaplastic carcinoma","author":"Reis-Filho","year":"2012"},{"key":"10.1038\/s41379-018-0081-z_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/nrc3637","article-title":"Metaplastic breast carcinoma: more than a special type","volume":"14","author":"Weigelt","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/s41379-018-0081-z_bib3","first-page":"40","article-title":"Metaplastic carcinomas of the breast. II. Spindle cell carcinoma","volume":"20","author":"Wargotz","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib4","first-page":"9","article-title":"Metaplastic carcinomas of the breast. III","volume":"64","author":"Wargotz","year":"1989","journal-title":"Carcinosarcoma Cancer"},{"key":"10.1038\/s41379-018-0081-z_bib5","first-page":"35","article-title":"Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma","volume":"20","author":"Wargotz","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00000478-199802000-00006","article-title":"Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements","volume":"22","author":"Chhieng","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ajcp\/aqv097","article-title":"A clinicopathologic analysis of 45 patients with metaplastic breast carcinoma","volume":"145","author":"Cimino-Mathews","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clbc.2017.04.009","article-title":"Metaplastic carcinoma of the breast is more aggressive than triple-negative breast cancer: a study from a single institution and review of literature","volume":"17","author":"El Zein","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1038\/s41379-018-0081-z_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-010-0780-8","article-title":"Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer","volume":"120","author":"Jung","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/s41379-018-0081-z_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-006-9301-1","article-title":"Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature","volume":"101","author":"Luini","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/s41379-018-0081-z_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2162-3619-2-31","article-title":"Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies","volume":"2","author":"Schwartz","year":"2013","journal-title":"Exp Hematol Oncol"},{"key":"10.1038\/s41379-018-0081-z_bib12","doi-asserted-by":"crossref","first-page":"e0131409","DOI":"10.1371\/journal.pone.0131409","article-title":"Clinicopathological features and prognosis of metaplastic breast carcinoma: experience of a Major Chinese Cancer Center","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1038\/s41379-018-0081-z_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1477-7819-11-129","article-title":"Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators","volume":"11","author":"Song","year":"2013","journal-title":"World J Surg Oncol"},{"key":"10.1038\/s41379-018-0081-z_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2014.592","article-title":"Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study","volume":"112","author":"Rakha","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-018-0081-z_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clbc.2016.06.002","article-title":"Management and outcomes in metaplastic breast cancer","volume":"16","author":"Tzanninis","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1038\/s41379-018-0081-z_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10549-008-0197-9","article-title":"Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis","volume":"117","author":"Weigelt","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/s41379-018-0081-z_bib17","first-page":"51","article-title":"Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected]","volume":"28","author":"Weigelt","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/0008-5472.CAN-08-3441","article-title":"Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics","volume":"69","author":"Hennessy","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-018-0081-z_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2635","article-title":"Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer","volume":"12","author":"Prat","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1038\/s41379-018-0081-z_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-017-0048-0","article-title":"Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast","volume":"3","author":"Piscuoglio","year":"2017","journal-title":"NPJ Breast Cancer"},{"key":"10.1038\/s41379-018-0081-z_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jamaoncol.2016.5281","article-title":"Targeting the PI3K\/AKT\/mTOR pathway for the treatment of mesenchymal triple-negative breast cancer: evidence from a phase 1 trial of mTOR inhibition in combination with liposomal doxorubicin and bevacizumab","volume":"3","author":"Basho","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1038\/s41379-018-0081-z_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/jclinpath-2016-203874","article-title":"Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1","volume":"70","author":"Joneja","year":"2017","journal-title":"J Clin Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/annonc\/mdv163","article-title":"Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer","volume":"26","author":"Moulder","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-018-0081-z_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1158\/1078-0432.CCR-16-2857","article-title":"The landscape of somatic genetic alterations in metaplastic breast carcinomas","volume":"23","author":"Ng","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-018-0081-z_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/path.2004","article-title":"EGFR amplification and lack of activating mutations in metaplastic breast carcinomas","volume":"209","author":"Reis-Filho","year":"2006","journal-title":"J Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5858\/arpa.2014-0200-OA","article-title":"Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options","volume":"139","author":"Ross","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-018-0081-z_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/path.2675","article-title":"Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas","volume":"220","author":"Geyer","year":"2010","journal-title":"J Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/path.1624","article-title":"p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components","volume":"204","author":"Lien","year":"2004","journal-title":"J Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1098-2264(199806)22:2<145::AID-GCC9>3.0.CO;2-X","article-title":"Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin","volume":"22","author":"Teixeira","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/s41379-018-0081-z_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/modpathol.3880456","article-title":"Metaplastic carcinoma of the breast: p53 analysis identified the same point mutation in the three histologic components","volume":"14","author":"Wang","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib31","first-page":"62","article-title":"Identical clonality of both components of mammary carcinosarcoma with differential loss of heterozygosity","volume":"10","author":"Zhuang","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/modpathol.2017.32","article-title":"Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas","volume":"30","author":"Krings","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/modpathol.2016.97","article-title":"Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase\/RAS signaling pathways and provides insights into intratumoral heterogeneity","volume":"29","author":"Liu","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-018-0081-z_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows\u2013Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-018-0081-z_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-018-0081-z_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"10.1038\/s41379-018-0081-z_bib38","doi-asserted-by":"crossref","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"10.1038\/s41379-018-0081-z_bib39","doi-asserted-by":"crossref","first-page":"11 0 1","DOI":"10.1002\/0471250953.bi1110s43","article-title":"From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Curr Protoc Bioinform"},{"key":"10.1038\/s41379-018-0081-z_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nprot.2015.105","article-title":"Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR","volume":"10","author":"Yang","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1038\/s41379-018-0081-z_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/bioinformatics\/btp394","article-title":"Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads","volume":"25","author":"Ye","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-018-0081-z_bib42","doi-asserted-by":"crossref","first-page":"i9","DOI":"10.1093\/bioinformatics\/bts378","article-title":"DELLY: structural variant discovery by integrated paired-end and split-read analysis","volume":"28","author":"Rausch","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-018-0081-z_bib43","first-page":"3907","volume":"1207","author":"Garrison","year":"2012","journal-title":"Haplotype-Based Var Detect Short-Read Seq arXiv"},{"key":"10.1038\/s41379-018-0081-z_bib44","unstructured":"Picard: A set of tools (in Java) for working with next generation sequencing data in the BAM: Broad Institute. http:\/\/broadinstitute.github.io\/picard."},{"key":"10.1038\/s41379-018-0081-z_bib45","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1038\/s41379-018-0081-z_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1038\/s41379-018-0081-z_bib47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1078-0432.CCR-13-0583","article-title":"New strategies for triple-negative breast cancer-deciphering the heterogeneity","volume":"20","author":"Mayer","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-018-0081-z_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1200\/JCO.2011.38.2010","article-title":"Dissecting the heterogeneity of triple-negative breast cancer","volume":"30","author":"Metzger-Filho","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-018-0081-z_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/npjbcancer.2016.36","article-title":"Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants","volume":"2","author":"Pareja","year":"2016","journal-title":"NPJ Breast Cancer"},{"key":"10.1038\/s41379-018-0081-z_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/1541-7786.MCR-16-0003","article-title":"Understanding TERT promoter mutations: a common path to immortality","volume":"14","author":"Bell","year":"2016","journal-title":"Mol Cancer Res"},{"key":"10.1038\/s41379-018-0081-z_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.18632\/oncotarget.20560","article-title":"TERT promoter status and gene copy number gains: effect on TERT expression and association with prognosis in breast cancer","volume":"8","author":"Gay-Bellile","year":"2017","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-018-0081-z_bib52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1073\/pnas.1303607110","article-title":"TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal","volume":"110","author":"Killela","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41379-018-0081-z_bib53","first-page":"6","article-title":"TERT promoter hotspot mutations in breast cancer","volume":"25","author":"Shimoi","year":"2017","journal-title":"Breast Cancer"},{"key":"10.1038\/s41379-018-0081-z_bib54","doi-asserted-by":"crossref","first-page":"E1550","DOI":"10.1210\/jc.2015-2690","article-title":"Association of TERT promoter mutation, but not BRAF mutation, with increased mortality in PTC","volume":"100","author":"George","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-018-0081-z_bib55","doi-asserted-by":"crossref","unstructured":"Griewank KG, Murali R, Puig-Butille JA, et al. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma. J Natl Cancer Inst 2014;106.dju246","DOI":"10.1093\/jnci\/dju246"},{"key":"10.1038\/s41379-018-0081-z_bib56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/cjp2.52","article-title":"ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis","volume":"2","author":"Gay-Bellile","year":"2016","journal-title":"J Pathol Clin Res"},{"key":"10.1038\/s41379-018-0081-z_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2893","article-title":"Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome","volume":"13","author":"Lu","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1038\/s41379-018-0081-z_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1158\/0008-5472.CAN-13-2498","article-title":"TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine","volume":"73","author":"Kinde","year":"2013","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-018-0081-z_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3218","article-title":"High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions","volume":"4","author":"Nault","year":"2013","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-018-0081-z_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/path.4672","article-title":"Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression","volume":"238","author":"Piscuoglio","year":"2016","journal-title":"J Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib61","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-015-0586-z","article-title":"Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast","volume":"17","author":"Pang","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1038\/s41379-018-0081-z_bib62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/modpathol.2017.21","article-title":"Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer","volume":"30","author":"Pang","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/path.3990","article-title":"Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection","volume":"227","author":"Hernandez","year":"2012","journal-title":"J Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib64","first-page":"607","article-title":"Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-018-0081-z_bib65","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/0008-5472.CAN-15-0506","article-title":"A molecular portrait of high-grade ductal carcinoma in situ","volume":"75","author":"Abba","year":"2015","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-018-0081-z_bib66","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/0008-5472.CAN-08-2660","article-title":"PIK3CA mutations in in situ and invasive breast carcinomas","volume":"70","author":"Miron","year":"2010","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-018-0081-z_bib67","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s001090100269","article-title":"The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer","volume":"79","author":"Kang","year":"2001","journal-title":"J Mol Med"},{"key":"10.1038\/s41379-018-0081-z_bib68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molonc.2009.03.001","article-title":"Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution","volume":"3","author":"Zhou","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1038\/s41379-018-0081-z_bib69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1158\/1078-0432.CCR-07-1465","article-title":"Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast","volume":"14","author":"Vincent-Salomon","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-018-0081-z_bib70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0b013e31817f9790","article-title":"Most basal-like breast carcinomas demonstrate the same Rb-\/p16 + immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically","volume":"33","author":"Subhawong","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib71","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molonc.2013.07.005","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: revisited","volume":"7","author":"Cowell","year":"2013","journal-title":"Mol Oncol"},{"key":"10.1038\/s41379-018-0081-z_bib72","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3239","article-title":"FGFR1 is amplified during the progression of in situ to invasive breast carcinoma","volume":"14","author":"Jang","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1038\/s41379-018-0081-z_bib73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/path.1385","article-title":"Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas","volume":"201","author":"Robanus-Maandag","year":"2003","journal-title":"J Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm.4279","article-title":"Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples","volume":"23","author":"Martelotto","year":"2017","journal-title":"Nat Med"},{"key":"10.1038\/s41379-018-0081-z_bib75","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/path.2872","article-title":"Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation?","volume":"224","author":"van Deurzen","year":"2011","journal-title":"J Pathol"},{"key":"10.1038\/s41379-018-0081-z_bib76","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1158\/1078-0432.CCR-17-0108","article-title":"Whole-exome sequencing of metaplastic breast carcinoma indicates monoclonality with associated ductal carcinoma component","volume":"23","author":"Avigdor","year":"2017","journal-title":"Clin Cancer Res"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0081-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522260005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522260005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:57:47Z","timestamp":1760230667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522260005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S089339522260005X"],"URL":"https:\/\/doi.org\/10.1038\/s41379-018-0081-z","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-018-0081-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}